Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for Dna X (SONM) over the last 7 years, with Q3 2025 value amounting to 31.92%.

  • Dna X's Return on Invested Capital rose 327200.0% to 31.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 31.92%, marking a year-over-year increase of 327200.0%. This contributed to the annual value of 4.06% for FY2024, which is 40800.0% down from last year.
  • Latest data reveals that Dna X reported Return on Invested Capital of 31.92% as of Q3 2025, which was up 327200.0% from 25.61% recorded in Q2 2025.
  • Over the past 5 years, Dna X's Return on Invested Capital peaked at 31.92% during Q3 2025, and registered a low of 7.02% during Q4 2024.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.71% (2022), whereas its average is 2.16%.
  • Per our database at Business Quant, Dna X's Return on Invested Capital plummeted by -70300bps in 2024 and then soared by 327200bps in 2025.
  • Dna X's Return on Invested Capital (Quarter) stood at 2.42% in 2021, then soared by 70bps to 0.71% in 2022, then soared by 101bps to 0.01% in 2023, then plummeted by -66017bps to 7.02% in 2024, then skyrocketed by 555bps to 31.92% in 2025.
  • Its last three reported values are 31.92% in Q3 2025, 25.61% for Q2 2025, and 9.01% during Q1 2025.